1. Efficacy of Intra-Cystic Methotrexate Injection in Management of Benign Persistent Ovarian Cysts
- Author
-
Adel El Gergawy, Mohamed E. Kabeil, Ayman Shehata Dawood, and Ahmed El Halwagy
- Subjects
medicine.medical_specialty ,030219 obstetrics & reproductive medicine ,Simple Ovarian Cyst ,business.industry ,Methotrexate Injection ,Mean age ,Benign Ovarian Cyst ,medicine.disease ,Surgery ,law.invention ,03 medical and health sciences ,Pregnancy rate ,0302 clinical medicine ,Randomized controlled trial ,law ,030220 oncology & carcinogenesis ,medicine ,Methotrexate ,Cyst ,business ,medicine.drug - Abstract
Aim: To evaluate and compare the efficacy of methotrexate injection in management of persistent simple ovarian cyst versus the use of transvaginal ultrasound aspiration alone. Patients and Methods: This randomized controlled study was conducted at Tanta University Hospitals in the period from April 1, 2016 to October 31, 2016. Patients were randomly allocated into two groups; each group has 25 patients with benign persistent simple ovarian cyst. Group I: Patients were subjected to transvaginal aspiration of the cyst. Group II: patients were subjected to methotrexate injection inside the cyst. Patients in both group were followed up at 1, 3, 6 months after procedure for the recurrence and occurrence spontaneous pregnancy. Results: The mean age in group I was 28.8 years, and the mean age in group II was 26.52 years with non-significant difference. Also there was non-significant difference between both groups regarding size of the cyst. No case recorded to have a cyst recurrence in group II and four cases in group I within six months with significant difference (P value 0.037), and there was non-significant differences as regard the pregnancy rate and complications. Conclusion: Transvaginal intra-cystic methotrexate injection is a safe and effective choice for management of persistent simple benign ovarian cyst.
- Published
- 2017